Streamline Your Market Entry In Asia

Fast Track Registration for US and European New and Orphan Drugs in Macau, Entering the Asian Market

  • Quick 30-90 Day Registration in Macau
  • 100% Registration Success Rate
  • No Additional Clinical Trials
  • Zero Additional Investments
  • 40 New Drugs Registered Last Year Alone
Expanding Access, Enhancing Capabilities
  • Broad Distribution Network: After registration, all drugs become eligible for distribution across major hospitals in the Guangdong Great Bay Area, Hainan, and Tianjin, serving over 120 million people.
  • Reaching Far and Wide: Our extensive network ensures medications are swiftly available to a vast patient base, opening access to an additional 1.2 billion people in Northern China. Patients can travel to these hospitals for critical treatments.
  • Life-Changing Solutions for Rare Diseases: Pediatric orphan drugs benefit from direct access to top hospitals in Beijing through a special program. These hospitals treat 50% of China’s rare disease patients, providing broader access to all patients across the country who can afford the treatment, without the need for national registration.

Accelerate access to treatment with Fast Track Registration in Macau for drugs addressing unmet medical needs. Our streamlined process offers US orphan drug manufacturers a swift market entry in China, allowing for quick recovery of their development investments.

Scroll to Top